136 related articles for article (PubMed ID: 35584612)
1. The need for multicomponent gas standards for breath biomarker analysis.
Jeerage KM; Berry JL; Murray JA; Goodman CA; Piotrowski PK; Jones CM; Cecelski CE; Carney J; Lippa KA; Lovestead TM
J Breath Res; 2022 Jul; 16(4):. PubMed ID: 35584612
[TBL] [Abstract][Full Text] [Related]
2. Breath Biomarkers in Diagnostic Applications.
Pham YL; Beauchamp J
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576985
[TBL] [Abstract][Full Text] [Related]
3. Towards standardization in the analysis of breath gas volatiles.
Herbig J; Beauchamp J
J Breath Res; 2014 Sep; 8(3):037101. PubMed ID: 25189420
[TBL] [Abstract][Full Text] [Related]
4. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath analysis in interstitial lung disease.
van der Sar IG; Wijsenbeek MS; Moor CC
Curr Opin Pulm Med; 2023 Sep; 29(5):443-450. PubMed ID: 37405699
[TBL] [Abstract][Full Text] [Related]
6. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Smith D; Španěl P
J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
[TBL] [Abstract][Full Text] [Related]
7. Exhaled breath testing - A tool for the clinician and researcher.
Davis MD; Fowler SJ; Montpetit AJ
Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
[TBL] [Abstract][Full Text] [Related]
8. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
9. A European Respiratory Society technical standard: exhaled biomarkers in lung disease.
Horváth I; Barnes PJ; Loukides S; Sterk PJ; Högman M; Olin AC; Amann A; Antus B; Baraldi E; Bikov A; Boots AW; Bos LD; Brinkman P; Bucca C; Carpagnano GE; Corradi M; Cristescu S; de Jongste JC; Dinh-Xuan AT; Dompeling E; Fens N; Fowler S; Hohlfeld JM; Holz O; Jöbsis Q; Van De Kant K; Knobel HH; Kostikas K; Lehtimäki L; Lundberg J; Montuschi P; Van Muylem A; Pennazza G; Reinhold P; Ricciardolo FLM; Rosias P; Santonico M; van der Schee MP; van Schooten FJ; Spanevello A; Tonia T; Vink TJ
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446552
[TBL] [Abstract][Full Text] [Related]
10. Exhaled Breath Analysis for Diabetes Diagnosis and Monitoring: Relevance, Challenges and Possibilities.
Dixit K; Fardindoost S; Ravishankara A; Tasnim N; Hoorfar M
Biosensors (Basel); 2021 Nov; 11(12):. PubMed ID: 34940233
[TBL] [Abstract][Full Text] [Related]
11. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of sampling parameters for standardised exhaled breath sampling.
Doran SLF; Romano A; Hanna GB
J Breath Res; 2017 Dec; 12(1):016007. PubMed ID: 29211685
[TBL] [Abstract][Full Text] [Related]
13. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
14. Novel extraction of volatile biomarkers from canine breath for gas chromatography-mass spectrometry.
Dissanayake S; Lathan P; Mlsna T
J Breath Res; 2012 Dec; 6(4):041001. PubMed ID: 22989995
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of exhaled breath vapor and exhaled breath aerosol using filter-incorporated needle-trap devices: A comparison of gas-phase and droplet-bound components.
Zeinali S; Ghosh C; Pawliszyn J
Anal Chim Acta; 2022 Apr; 1203():339671. PubMed ID: 35361425
[TBL] [Abstract][Full Text] [Related]
16. The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review.
Terrington DL; Hayton C; Peel A; Fowler SJ; Fraser W; Wilson AM
J Breath Res; 2019 Jun; 13(3):036015. PubMed ID: 30901768
[TBL] [Abstract][Full Text] [Related]
17. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
[TBL] [Abstract][Full Text] [Related]
18. Volatile Organic Compounds in Human Breath.
Karunagaran M; Ramani P; Gheena S; Abilasha R; Hannah R
Indian J Dent Res; 2022; 33(1):100-104. PubMed ID: 35946254
[TBL] [Abstract][Full Text] [Related]
19. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
20. Modeling-based determination of physiological parameters of systemic VOCs by breath gas analysis, part 2.
Ager C; Unterkofler K; Mochalski P; Teschl S; Teschl G; Mayhew CA; King J
J Breath Res; 2018 Apr; 12(3):036011. PubMed ID: 29488464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
